An interventional study of VR therapy and VR sham in Bipolar Disorder, VR and Interventional Study, sponsored by Shanghai Mental Health Center. Recruiting at 1 site in China. Open to participants aged 13 Years and older. Per ClinicalTrials.gov, last updated 2024-05-03.
Sponsored by Shanghai Mental Health Center · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Bipolar Disorder by Shanghai Mental Health Center — 7 open to participants now, 7 under way, none of them phase 3. Bipolar Disorder · Shanghai Mental Health Center.
Among the 16 studies in Bipolar Disorder by Shanghai Mental Health Center, this one is one of 4 that started in 2024, is one of 4 with no phase, and was the 11th registered.
1,687 studies on the registry are indexed under Bipolar Disorder; 268 are open to participants now.
Browse Bipolar Disorder studies →7 of the 16 studies in Bipolar Disorder by Shanghai Mental Health Center are open now, in 1 country. Recruiting first, the newest first:
Shanghai Mental Health Center · Sites in China
Ages 18–64 · Healthy volunteers
Shanghai Mental Health Center · Sites in China
Ages 6–18 · Healthy volunteers
Shanghai Mental Health Center · Sites in China
Ages 18+
Shanghai Mental Health Center · Sites in China
Ages 18–65
Shanghai Mental Health Center · Sites in China
Ages 12+ · Healthy volunteers
By country, each count listing its studies:
Of the 207 Bipolar Disorder studies recruiting now, 60 (29%) set no upper age limit and 134 (65%) stop at 75 or younger; 38 take children under 18; 51 take healthy volunteers.
This study: 13 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 4 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 48 is below the median of 64 across 1,282 interventional studies indexed under Bipolar Disorder.
Median enrollment 65 across the 8 interventional studies, 1,100 across the 8 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Shanghai Mental Health Center is the lead sponsor of 277 studies on the registry; 95 are open to participants now.
1 of the studies in Bipolar Disorder by Shanghai Mental Health Center that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06417437Shanghai Mental Health CenterNon-invasive BCI and Application Verification for Depressed People | 2027-07-31 |
Add it to your calendar (.ics) → With an account.
Among the 16 studies in Bipolar Disorder by Shanghai Mental Health Center, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Bipolar disorder is characterized by high morbidity, recurrence, disability, suicide and comorbidity rate which need novel, efficient, and safe treatment methods, and VR has demonstrate its efficacy in mental disease but not few focus on bipolar disorder. A prospective single center randomize clinical study therefore would be carried on to evaluate the efficacy of VR for Bipolar Disorder in China.
Bipolar disorder (BD) refers to a type of mood disorder that clinically manifests as both manic or hypomanic episodes and depressive episodes. Bipolar disorder is characterized by high morbidity, recurrence, disability, suicide and comorbidity rate. The first episode often occurs before age 20, with a lifetime morbidity rate ranging from 1.5% to 6.4% . Patients with bipolar disorder spend significantly more time experiencing depressive episodes than manic or mixed symptoms throughout their lives. At the same time, depressive episodes can cause severe psycho-social disabilities, imposing a heavy economic burden on their families and society .
Despite being the first-line recommended treatment for bipolar depression, pharmacotherapy still cannot fully meet the clinical needs. Some patients do not achieve clinical remission even after receiving adequate and full-course pharmacotherapy. Even if clinical remission is achieved, many patients still have residual symptoms, and those in the maintenance phase still face a high risk of relapse. Psychotherapy has been reported to have various benefits such as improving interpersonal communication skills, enhancing cohesion, and building social support systems, and it has been widely used in the treatment of depression. Although psychological intervention plays a crucial role in the treatment of bipolar depression, its application in reality is still limited. One important reason is the shortage of psychological treatment service resources.
The application of virtual reality (VR) technology in the treatment of mental illnesses has overcome the limitations of traditional psychotherapy techniques. It provides a safer, more controllable, and personalized treatment approach, enabling patients to experience environments and events more intuitively and vividly. This study aims to explore the clinical intervention effects of a mental disorder adjuvant treatment software developed by Nanjing XR-Oasis Technology Co., Ltd. on patients with bipolar disorder experiencing depressive episodes. The technology is based on the theoretical frameworks of cognitive behavioral therapy, interpersonal therapy, mental health education, and Naikan therapy, combined with VR technology.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device: VR therapy
Device: VR sham
Participants this group received additional VR therapy , with a total 20 sessions over a period of 4 weeks based on routine treatment.
Participants in this group received additional VR sham(health education videos,a total of 20 health education videos over a period of 4 weeks) under virtual reality conditions on the basis of routine treatment.
Evolution of Depression
Changes in the total score of HAMD-17 at the end of the study compared to baseline
Time frame: 1 month
Early Response
A reduction of ≥20% in the total score of HAMD-17 at the end of the 2nd week of treatment compared to baseline
Time frame: 2 weeks
Clinical Response
A reduction of ≥50% in the total score of HAMD-17 compared to baseline; specifically, sustained response is defined as a continuous reduction of ≥50% in the total score of HAMD-17 at the end of the 4th and 8th weeks of treatment compared to baseline
Time frame: 2 months
Clinical Remission
A total score of HAMD-17 ≤7; particularly, complete remission is defined as a total score of HAMD-17 ≤7 at the end of both the 4th and 8th weeks of treatment
Time frame: 2 months
Changes in the Clinical Global Impression Scale
Improvement (CGI-I) and Severity (CGI-S) scores compared to baseline
Time frame: 2 months
Conversion to mania
Change of A Young Mania Rating Scale(YMRS) \>13 before and after treatment, and 1 month follow-up
Time frame: 2 months
Changes in Patient Satisfaction Scale
Changes in patients satisfaction scale before and after treatment, and 1 month follow-up
Time frame: 2 months
Change in biological rhythms
Change in Biological Rhythms Interview of Assessment in Neuropsychiatry(BRAIN) Scale before and after treatment, and 1 month follow-up
Time frame: 2 months
Change in Quality of life
Change in quality of life score before and after treatment, and 1 month follow-up
Time frame: 2 months
Intervention Acceptability
Acceptability was assessed by questions, "Rate the VR storyline on a scale of 0 to 5". Acceptability was measured with total score of the scale
Time frame: 2 months
Adverse Events
Change of Treatment Emergent Symptom Scale(TESS)before and after treatment, and 1 month follow-up
Time frame: 2 months
Plan to share: No — The prescription data will not be shared with the public. However, if the intervention is effective, the educational materials will be released to the public.
No publications or documents are linked to this record.
Started Mar 2024 (actual). Primary completion is estimated for Dec 2024, 9 months after the start.
Of 361 non-industry interventional studies with no phase under Bipolar Disorder, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 58. This study's planned 9 months is below that.
Counting every sponsor, half of 363 studies reached it within 37 months; a quarter within 23 and three quarters within 58.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai Mental Health Center →